186 related articles for article (PubMed ID: 28797765)
1. Patterns of Fractionation and Boost Usage in Adjuvant External Beam Radiotherapy for Ductal Carcinoma in Situ in the United States.
Stokes WA; Amini A; Jackson MW; Plimpton SR; Kounalakis N; Kabos P; Rabinovitch RA; Rusthoven CG; Fisher CM
Clin Breast Cancer; 2018 Jun; 18(3):220-228. PubMed ID: 28797765
[TBL] [Abstract][Full Text] [Related]
2. Implementation of hypofractionated prostate radiation therapy in the United States: A National Cancer Database analysis.
Stokes WA; Kavanagh BD; Raben D; Pugh TJ
Pract Radiat Oncol; 2017; 7(4):270-278. PubMed ID: 28673554
[TBL] [Abstract][Full Text] [Related]
3. Ductal Carcinoma in Situ: A French National Survey. Analysis of 2125 Patients.
Cutuli B; Lemanski C; De Lafontan B; Chauvet MP; De Lara CT; Mege A; Fric D; Richard-Molard M; Mazouni C; Cuvier C; Carre A; Kirova Y
Clin Breast Cancer; 2020 Apr; 20(2):e164-e172. PubMed ID: 31780381
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Care for Patients With Early-Stage Glottic Cancer Undergoing Definitive Radiation Therapy: A National Cancer Database Analysis.
Stokes WA; Abbott D; Phan A; Raben D; Lanning RM; Karam SD
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1014-1021. PubMed ID: 28721883
[TBL] [Abstract][Full Text] [Related]
5. Trends and Patterns of Utilization of Hypofractionated Postmastectomy Radiotherapy: A National Cancer Database Analysis.
Venigalla S; Guttmann DM; Jain V; Sharma S; Freedman GM; Shabason JE
Clin Breast Cancer; 2018 Oct; 18(5):e899-e908. PubMed ID: 29550285
[TBL] [Abstract][Full Text] [Related]
6. Variations in treatment for ductal carcinoma in situ in elderly women.
Gold HT; Dick AW
Med Care; 2004 Mar; 42(3):267-75. PubMed ID: 15076826
[TBL] [Abstract][Full Text] [Related]
7. Trends in the treatment of ductal carcinoma in situ of the breast.
Baxter NN; Virnig BA; Durham SB; Tuttle TM
J Natl Cancer Inst; 2004 Mar; 96(6):443-8. PubMed ID: 15026469
[TBL] [Abstract][Full Text] [Related]
8. Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trials.
Jagsi R; Falchook AD; Hendrix LH; Curry H; Chen RC
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1001-9. PubMed ID: 25539365
[TBL] [Abstract][Full Text] [Related]
9. Trends in the use of implantable accelerated partial breast irradiation for ductal carcinoma in situ: Implications of the recent amendments to the American Society for Radiation Oncology consensus guidelines.
Haque W; Verma V; Haque A; Butler EB; Teh BS
Brachytherapy; 2017; 16(2):402-408. PubMed ID: 28063816
[TBL] [Abstract][Full Text] [Related]
10. Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma In Situ.
Park HL; Chang J; Lal G; Lal K; Ziogas A; Anton-Culver H
Clin Breast Cancer; 2018 Apr; 18(2):e179-e185. PubMed ID: 28941977
[TBL] [Abstract][Full Text] [Related]
11. Prescribing practices of endocrine therapy for ductal carcinoma
Chaudhry AT; Koulis TA; Speers C; Olson RA
Curr Oncol; 2018 Apr; 25(2):133-138. PubMed ID: 29719429
[TBL] [Abstract][Full Text] [Related]
12. Has Hypofractionated Whole-Breast Radiation Therapy Become the Standard of Care in the United States? An Updated Report from National Cancer Database.
Kang MM; Hasan Y; Waller J; Saulsberry L; Huo D
Clin Breast Cancer; 2022 Jan; 22(1):e8-e20. PubMed ID: 34257001
[TBL] [Abstract][Full Text] [Related]
13. Variation in the management of ductal carcinoma in situ in the UK: Results of the Mammary Fold National Practice Survey.
Mammary Fold Academic and Research Collaborative
Eur J Surg Oncol; 2016 Aug; 42(8):1153-61. PubMed ID: 27344543
[TBL] [Abstract][Full Text] [Related]
14. Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
Worni M; Akushevich I; Greenup R; Sarma D; Ryser MD; Myers ER; Hwang ES
J Natl Cancer Inst; 2015 Dec; 107(12):djv263. PubMed ID: 26424776
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated radiation in older women with breast cancer.
Wallace AS; Keene KS; Williams CP; Jackson BE; Pisu M; Rocque GB
Breast J; 2019 Nov; 25(6):1206-1213. PubMed ID: 31359556
[TBL] [Abstract][Full Text] [Related]
16. Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ.
Williamson D; Dinniwell R; Fung S; Pintilie M; Done SJ; Fyles AW
Radiother Oncol; 2010 Jun; 95(3):317-20. PubMed ID: 20400190
[TBL] [Abstract][Full Text] [Related]
17. Long-term Impact of CALGB 9343 on Radiation Utilization.
Squeo G; Malpass JK; Meneveau M; Balkrishnan R; Desai RP; Lattimore C; Anderson RT; Showalter SL
J Surg Res; 2020 Dec; 256():577-583. PubMed ID: 32805580
[TBL] [Abstract][Full Text] [Related]
18. Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013.
Sagara Y; Freedman RA; Wong SM; Aydogan F; Nguyen A; Barry WT; Golshan M
Breast Cancer Res Treat; 2017 Nov; 166(2):583-592. PubMed ID: 28776282
[TBL] [Abstract][Full Text] [Related]
19. American Society of Breast Surgeons' Practice Patterns After Publication of the SSO-ASTRO-ASCO DCIS Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation.
DeSnyder SM; Hunt KK; Dong W; Smith BD; Moran MS; Chavez-MacGregor M; Shen Y; Kuerer HM; Lucci A
Ann Surg Oncol; 2018 Oct; 25(10):2965-2974. PubMed ID: 29987598
[TBL] [Abstract][Full Text] [Related]
20. Twenty-year outcomes after breast-conserving surgery and definitive radiotherapy for mammographically detected ductal carcinoma in situ.
Wilkinson JB; Vicini FA; Shah C; Shaitelman S; Jawad MS; Ye H; Kestin LL; Goldstein NS; Martinez AA; Benitez P; Chen PY
Ann Surg Oncol; 2012 Nov; 19(12):3785-91. PubMed ID: 22644510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
